SciELO - Scientific Electronic Library Online

 
vol.147 número4Angioplastía con balón para el tratamiento de la hipertensión arterial pulmonar por enfermedad tromboembólica crónica. Resultados hemodinámicos y clínicos inmediatosModelo de manejo en red y por telemedicina de la retinopatía diabética en dos comunas del Servicio de Salud Metropolitano Oriente índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

CABRERA C., María Elena; PUGA L., Bárbara; TORRES, Vivianne  y  SALINAS, Mauricio. Treatment of Hodgkin lymphoma. Analysis of 915 patients. Rev. méd. Chile [online]. 2019, vol.147, n.4, pp.437-443. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872019000400437.

Background:

Hodgkin lymphoma has a high rate of curability, even in advanced stages.

Aim:

To assess the results of Hodgkin lymphoma treatment using the ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy regimen.

Material and Methods:

Analysis of a database held by the Chilean Ministry of Health, including all patients treated at accredited cancer treatment centers.

Results:

Data for 915 patients, median age 35 years (range 15-86 years) and followed for a median of 97 months (range 1-347 months) were analyzed. Forty-one percent had localized disease. Overall survival at five years for localized and advanced stages was 92% and 74%, respectively. The figures for progression free survival were 87% and 64%, respectively. Patients with relapse who received autologous stem cell transplantation (ASCT) had a five year overall survival of 92%, compared to 64% among those who did not undergo this procedure (p < 0.01). The Guarantees in Health Program set up by the Ministry of Health, was associated with earlier stage disease at diagnosis.

Conclusions:

The ABVD regimen achieves high rates of cure in localized stages of the disease but the results in advanced stages are not optimal. ASCT significantly improves survival in patients with relapse. The Guarantees in Health Program is associated with earlier diagnosis of the disease.

Palabras clave : Drug Therapy; Hodgkin Disease; Stem Cell Transplantation; Survival.

        · texto en Español     · Español ( pdf )